At MME, we know which concerns are top of mind for our clients at any given time. In today’s COVID-impacted world, that begins with developing a comprehensive understanding of how the pandemic is currently impacting payers. That is why MME recently commissioned a series of studies involving US payer pharmacy directors from our proprietary payer panel. The studies were geared to help our clients gain a better sense of how payers are affected in business, operational and activity prioritization activities.
In our first survey, payers reported concerns about unplanned cost increases, cancellations of business meetings and travel and disruptions to patient treatments—to name just a few. The PDF file is a topline summary of those findings; download using the link below.
In the next few weeks, we’ll continue to release more findings from our surveys on our website and social media channels.
If you’re interested, we would be happy to set up a web meeting to review the complete findings. This service is free to MME Customers.
